Fulgent Genetics(FLGT) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Fulgent Reports Third Quarter 2025 Financial Results EL MONTE, CA, November 7, 2025 — Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2025. For the full year 2025, Fulgent now expects: *Cash expenditures may be higher or lower than currently estimated due to a variety of factors an ...